BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29099150)

  • 1. Expanded carrier screening in gamete donors of Venezuela.
    Urbina MT; Benjamin I; Medina R; Jiménez J; Trías L; Lerner J
    JBRA Assist Reprod; 2017 Dec; 21(4):356-360. PubMed ID: 29099150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
    Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
    Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy: patterns of community and healthcare provider participation in a Victorian screening program.
    Leibowitz R; Lewis S; Emery J; Massie J; Smith M; Delatycki M; Archibald A
    Aust J Prim Health; 2022 Dec; 28(6):580-587. PubMed ID: 36192111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic testing of sperm donors for cystic fibrosis and spinal muscular atrophy: evaluation of clinical utility.
    Landaburu I; Gonzalvo MC; Clavero A; Ramirez JP; Yoldi A; Mozas J; Zamora S; Martinez L; Castilla JA
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):183-7. PubMed ID: 23866907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling and carrier screening in candidates for gamete donation at a Portuguese center.
    Soares CA; Tkachenko N; Vale-Fernandes E; Barreiro M; Abreu M; Reis CF; Soares G; Fortuna AM; Soares AR
    JBRA Assist Reprod; 2023 Jun; 27(2):180-184. PubMed ID: 35916466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance for genetic screening in the Arab population in Israel.
    Sukenik-Halevy R; Leil-Zoabi UA; Peled-Perez L; Zlotogora J; Allon-Shalev S
    Isr Med Assoc J; 2012 Sep; 14(9):538-42. PubMed ID: 23101415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and experience of implementing spinal muscular atrophy carrier screening on sperm donors.
    Callum P; Iger J; Ray M; Sims CA; Falk RE
    Fertil Steril; 2010 Oct; 94(5):1912-4. PubMed ID: 20152968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
    Beard CA; Amor DJ; Di Pietro L; Archibald AD
    Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of expanded carrier screening of gamete donors.
    Payne MR; Skytte AB; Harper JC
    Hum Reprod; 2021 May; 36(6):1702-1710. PubMed ID: 33842976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
    Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
    Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic status and uptake of reproductive carrier screening in Australia.
    Robson SJ; Caramins M; Saad M; Suthers G
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded carrier screening: A review of early implementation and literature.
    Lazarin GA; Haque IS
    Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded carrier screening for preconception reproductive risk assessment: Prevalence of carrier status in a Mexican population.
    Hernandez-Nieto C; Alkon-Meadows T; Lee J; Cacchione T; Iyune-Cojab E; Garza-Galvan M; Luna-Rojas M; Copperman AB; Sandler B
    Prenat Diagn; 2020 Apr; 40(5):635-643. PubMed ID: 32003480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
    Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
    Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.